Dabbling here and there while in school working on a Computer Science degree from OSU. First degree was in Science from PSU. I enjoy the challenge investing has to offer. My main focus is on companies in the OTC market. Main sectors of interest: marijuana, robotics, biotechnology and pharm. / med. The scientist a great story about the grandfather of cannabis research Dr Mechoulam:https://www.youtube.com/watch?v=PWabJ6DS55Q (a documentary I find greatly informative and a good watch IMHO.)
iHub membership: Bluesummers (if you see snoopy in the rain and a red dog house - that's me).
OTC stocks I'm currently looking at / watching:
ELTP (anti-abuse pain medication; with ideal design behind them),
TRTC (medical / rec. marijuana products),
ASTI (solar portable products),
LMRMF (graphene supplier and manufacturer),
GPHBF (graphene 3D printing - partially owned by LMRMF), and
SFOR (key encryption software).
Non OTC stocks (mostly for capital preservation / portfolio diversification):
TWMJF (CAN marijuana),
OGI (CAN medical marijuana),
LEU (enriched uranium supplier),
SCTY (solar panels),
EBS (anthrax vaccine - only one approved by FDA),
PSTI (stromal cells for commercial use in disease treatment),
WTI (oil and gas Gulf of Mexico),
BADFF (CAN hydrovac excavation; costumer base: 51% oil and gas and 49% utility and municipality), and
BNO (oil fund).
Invested in: ELTP and LEU.
Watching: TRTC, TWMJF, GPHBF, and SFOR.
On my smartphone:
Alan Brochstein, CFA, was the first investment professional to devote himself to sharing his observations about the cannabis industry from an investor's perspective publicly. He runs 420 Investor, a subscription-based due diligence platform for investors interested in the publicly-traded cannabis stocks and is also the founder of New Cannabis Ventures, a content aggregation site focused on investors and entrepreneurs in the cannabis industry.
Alan has worked in the securities industry since 1986, primarily with the responsibility for managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent research and consulting to registered investment advisors. In addition to advising several different hedge funds and investment managers, including Friedberg Investment Management, where he participated as a member of its investment management committee, Alan was also a senior analyst for the independent research firm Management CV. In 2008, he began providing a first-of-its-kind subscription-based service for individual investors, Invest By Model, which offered two different portfolios that investors could replicate in their own accounts for $20 per month. Alan also offered The Analytical Trader at Marketfy, where he used fundamental and technical analysis in a disciplined process to offer specific trade ideas geared towards swing traders.
Alan launched www.420Investor.com in late 2013 as the premier source of information for "Green Rush" investors seeking to capitalize on the proliferation of legalized medical and recreational cannabis. In March 2014, Alan, who is a member of the National Cannabis Industry Association, began to focus solely on the cannabis sector. He launched www.NewCannabisVentures.com in late 2015.
You can follow Alan on Facebook (www.facebook.com/420investor) or on Twitter (https://twitter.com/Invest420). Alan also moderates a large LinkedIn group focused on the cannabis industry, Cannabis Investors & Entrepreneurs (https://www.linkedin.com/groups/6523904)